160 related articles for article (PubMed ID: 1832848)
1. Modulation of the HLA class II antigen at a molecular level by maternal serum among cord blood cells and unrelated lymphocytes.
Vanderbeeken YE; Duchateau J; Colle H; Gregoire M; Desseilles P; Lucas A
Arch Gynecol Obstet; 1991; 248(4):199-209. PubMed ID: 1832848
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the HLA class II antigen at a molecular level by maternal serum.
Vanderbeeken YE; Duchateau J; Colletl H; Gregoire M; Desseilles P; Lucas A
Immunopharmacol Immunotoxicol; 1990; 12(4):679-95. PubMed ID: 2092045
[TBL] [Abstract][Full Text] [Related]
3. Functional modifications of the CD4+ and the CD8+ subset due to maternal serum.
Vanderbeeken YE; Duchateau J; Collet H; Van Boogaert L; Desseilles P; Lucas A
Immunopharmacol Immunotoxicol; 1989; 11(2-3):397-420. PubMed ID: 2516095
[TBL] [Abstract][Full Text] [Related]
4. Modulation of class II histocompatibility antigen expression by maternal serum.
Vanderbeeken EY; Duchateau J; Vandermeersch B; Collet H; Lucas A
Dis Markers; 1990; 8(4):199-210. PubMed ID: 1708318
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
6. The interleukin-2 receptor on cord blood and nulliparous mononuclear cells is downregulated by maternal and cord blood serum.
Vanderbeeken YE; Duchateau J; Van Boogaert L; Desseilles P; Collet H; Lucas A
Immunol Cell Biol; 1990 Aug; 68 ( Pt 4)():243-51. PubMed ID: 2249873
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
8. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
[TBL] [Abstract][Full Text] [Related]
9. Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium.
Muczynski KA; Cotner T; Anderson SK
Kidney Int; 2001 Feb; 59(2):488-97. PubMed ID: 11168931
[TBL] [Abstract][Full Text] [Related]
10. Are soluble monocyte-derived HLA class II molecules candidates for immunosuppressive activity?
Claus R; Werner H; Schulze HA; Walzel H; Friemel H
Immunol Lett; 1990 Dec; 26(3):203-10. PubMed ID: 2150835
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.
Mann DL; Read-Connole E; Arthur LO; Robey WG; Wernet P; Schneider EM; Blattner WA; Popovic M
J Immunol; 1988 Aug; 141(4):1131-6. PubMed ID: 2840463
[TBL] [Abstract][Full Text] [Related]
12. In vitro inhibition of normal human hematopoiesis by marrow CD3+, CD8+, HLA-DR+, HNK1+ lymphocytes.
Vinci G; Vernant JP; Nakazawa M; Zohair M; Katz A; Henri A; Rochant H; Breton-Gorius J; Vainchenker W
Blood; 1988 Nov; 72(5):1616-21. PubMed ID: 2972326
[TBL] [Abstract][Full Text] [Related]
13. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
14. Expression of HLA class II antigens and secretion of interleukin-1 by monocytes and macrophages from adults and neonates.
Glover DM; Brownstein D; Burchett S; Larsen A; Wilson CB
Immunology; 1987 Jun; 61(2):195-201. PubMed ID: 3496273
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the interleukin 2 receptor by maternal and cord blood serum.
Vanderbeeken YE; Duchateau J; Van Boogaert L; Desseilles P; Collet H; Lucas A
Immunopharmacol Immunotoxicol; 1990; 12(2):211-36. PubMed ID: 2229922
[TBL] [Abstract][Full Text] [Related]
16. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
17. Regulation of HLA class II antigen expression on cultured corneal epithelium by interferon-gamma.
Iwata M; Kiritoshi A; Roat MI; Yagihashi A; Thoft RA
Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2714-21. PubMed ID: 1639617
[TBL] [Abstract][Full Text] [Related]
18. Allorecognition and T cell repertoire selection in severe combined immunodeficiency lacking HLA class II antigens.
Knobloch C; Ballas M; Wölpl A; Friedrich W
Transplantation; 1992 Jun; 53(6):1295-301. PubMed ID: 1534939
[TBL] [Abstract][Full Text] [Related]
19. Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes.
Herrmann T; Accolla RS; MacDonald HR
Eur J Immunol; 1989 Nov; 19(11):2171-4. PubMed ID: 2599004
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
